Twist Bioscience Corporation

Informe Stock NasdaqGS:TWST

Capitalización de mercado: US$1.7b

Twist Bioscience Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Emily Leproust

Chief Executive Officer (CEO)

US$8.0m

Compensación total

Porcentaje del salario del CEO8.6%
Permanencia del CEO11yrs
Participación del CEO0.4%
Permanencia media de la dirección2.9yrs
Promedio de permanencia en la Junta Directiva7.4yrs

Actualizaciones recientes de la dirección

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Recent updates

Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Twist Bioscience: Strong Performance In A Soft Market

Feb 07

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Jan 22
We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Dec 18
Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

Oct 05
Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Jul 07
We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Twist Biosciences collaborates with Enzolytics on monoclonal antibodies for viruses

Sep 16

Twist Bioscience: DNA Synthesis Leader Appealing 'Picks And Shovels' Play

Sep 02

Twist Bioscience: DNA Synthesis Leader Is Just Getting Started

Aug 08

Twist Bioscience/ Biotia sequencing assay granted FDA nod to detect COVID variants

Aug 02

Twist Biosciences to work with DNAnexus on sequencing-based diagnostic tests

Jul 13

Twist Bioscience, Ildong team up to discover antibodies for cancer therapies

Jun 30

Twist Bioscience: A First Take

May 26

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Emily Leproust en comparación con los beneficios de Twist Bioscience?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Jun 30 2019n/an/a

-US$96m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018n/an/a

-US$77m

Sep 30 2018US$525kUS$362k

-US$71m

Jun 30 2018n/an/a

-US$68m

Sep 30 2017US$2mUS$340k

-US$59m

Compensación vs. Mercado: Emily($USD8.00M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD4.98M).

Compensación vs. Ingresos: Emilyha aumentado mientras la empresa no es rentable.

CEO

Emily Leproust (50 yo)

11yrs

Permanencia

US$7,998,637

Compensación

Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Emily Leproust
Co-Founder11yrsUS$8.00m0.36%
$ 6.1m
Patrick Finn
President & COO1.5yrsUS$5.23m0.078%
$ 1.3m
Paula Green
Senior Vice President of Human Resources8.1yrsUS$2.49m0.030%
$ 509.9k
William Banyai
Senior VP of Advanced Development4.3yrsUS$2.82m0.44%
$ 7.5m
Adam Laponis
Chief Financial Officerless than a yearsin datos0.13%
$ 2.2m
Robert Werner
VP & Chief Accounting Officerless than a yearsin datos0.0017%
$ 28.1k
Siyuan Chen
Chief Technology Officer3.2yrssin datossin datos
Aaron Sato
Chief Scientific Officer3.2yrssin datossin datos
Chet Gandhi
Chief Information Officerless than a yearsin datossin datos
Dennis Cho
Senior VP2.6yrsUS$1.96m0.041%
$ 699.2k
Angela Bitting
Chief ESG Officer & Senior VP of Corporate Affairs3.2yrssin datossin datos
Tracey Mullen
Senior Vice President of Biopharma1.5yrssin datossin datos

2.9yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: TWSTEl equipo directivo de la empresa se considera experimentado (2.8 años de antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Emily Leproust
Co-Founder11yrsUS$8.00m0.36%
$ 6.1m
William Banyai
Senior VP of Advanced Development11yrsUS$2.82m0.44%
$ 7.5m
Keith Crandell
Independent Director10.5yrsUS$272.49k0.16%
$ 2.8m
Robert Chess
Lead Independent Director9.8yrsUS$303.98k0.11%
$ 1.9m
Nelson Chan
Independent Director4.9yrsUS$284.99k0.031%
$ 522.6k
Robert Ragusa
Independent Director7.4yrsUS$271.34k0.024%
$ 397.6k
Jan Johannessen
Independent Director5.5yrsUS$284.99k0.020%
$ 339.6k
Melissa Starovasnik
Independent Director2.7yrsUS$276.61k0.019%
$ 318.2k
Xiaoying Mai
Independent Director5.8yrsUS$269.99k0.044%
$ 738.1k

7.4yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: La junta directiva de TWST se considera experimentada (7.1 años de antigüedad promedio).